Home>Topics>Companies>Boston Scientific

Boston Scientific BSX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Endo Reports Strong Fundamentals as Auxilium Integration Remains Underway

      Commentary

      Mon, 11 May 2015

      additional outperformance over the remainder of the year, and the divestment of the AMS business later this year to Boston Scientific should give management greater resources for finding value-accretive deals, including the May 11 announcement

    2. Coloplast Sees Strong 2Q; No Change to Our Fair Value Estimate

      Commentary

      Tue, 5 May 2015

      soft demand for vaginal slings and penile implants. We expect Coloplast will refocus on penile implants now that Boston Scientific will soon close on its purchase of the men's urology business from Endo Pharmaceuticals. We anticipate Boston

    3. Boston Scientific Sees Decent 1Q, and Our Fair Value Estimate Remains Constant

      Commentary

      Wed, 29 Apr 2015

      Boston Scientific 's solid first-quarter results were largely consistent with our projections, and we are leaving our $13 fair value estimate

    4. UPDATE 1- Boston Scientific reaches first transvaginal mesh settlement

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.

    5. Boston Scientific says to settle some transvaginal mesh cases

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Boston Scientific Corp on Tuesday said it has reached an agreement to settle a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.

    6. Boston Scientific says reaches conditional settlement in some transvaginal mesh cases

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Boston scientific says it reached conditional agreement to settle some transvaginal mesh cases Boston scientific says it will pay about $119 million to resolve 2,970 cases Boston...

    7. UPDATE 1- Boston Scientific cuts full-year forecast as legal costs weigh

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits.

    8. Boston Scientific posts loss on litigation costs

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million.

    9. Edwards Lifesciences Off to a Strong Start in 2015; Our Fair Value Estimate is Unchanged

      Commentary

      Fri, 24 Apr 2015

      surgeon and interventional cardiologist teams that are already trained on the Sapien valve, we suspect St. Jude and Boston Scientific face a challenge in ramping up their own trained physician teams.

    10. Coloplast Moves Toward Settlement of Vaginal Mesh Cases

      Commentary

      Mon, 20 Apr 2015

      firm's exposure to liability is limited, especially compared with Johnson & Johnson, Endo Pharmaceuticals, and Boston Scientific . The firm settled 400 of the cases for $16 million, or roughly $20,000 per plaintiff. This is significantly

    « Prev12345Next »
    Content Partners